| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791064A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 08/27/1997 | EP0791063A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine |
| 08/27/1997 | EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 08/27/1997 | EP0791055A1 Method for producing biologicals in protein-free culture |
| 08/27/1997 | EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 08/27/1997 | EP0791053A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791050A1 Vectors for tissue-specific replication |
| 08/27/1997 | EP0790836A1 Serially passaged african green monkey kidney cells |
| 08/27/1997 | EP0790835A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/27/1997 | EP0790833A1 Process for identifying para cation channel modulators |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0594607B1 Enhancement of the down-regulation of autoimmune diseases by oral or enteral administration of autoantigens |
| 08/27/1997 | EP0536302B1 Improved adjuvants and vaccines |
| 08/27/1997 | EP0527724B1 Compositions and treatments for pneumonia in animals |
| 08/27/1997 | EP0524205B1 Live vaccines |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158134A Antibodies which activate an erythropoietin receptor |
| 08/27/1997 | CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same |
| 08/26/1997 | US5661015 Recombinant coccidiosis vaccines |
| 08/26/1997 | US5661010 Incubating entamoeba histolytica trophozoites in medium modified by elimination of l-cysteine, serum, and vitamins and addition of type i collagen and calcium |
| 08/26/1997 | US5661006 Polynucleotides genetic engineering a vaccines |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660978 Stabilization of analytes |
| 08/26/1997 | US5660834 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | CA1339367C Purified hematoporphyrin trimers useful in photodynamic therapy |
| 08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
| 08/26/1997 | CA1339363C Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
| 08/26/1997 | CA1339362C Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
| 08/26/1997 | CA1339346C Recombinant chimeric vaccine |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030171A1 Polysaccharide precipitation process |
| 08/21/1997 | WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | WO1997030158A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030147A1 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 08/21/1997 | WO1997030081A1 Ebna2 peptides and methods of using same |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | WO1997029781A1 Methods and compositions for modulating an immune response |
| 08/21/1997 | WO1997029773A1 Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same |
| 08/21/1997 | WO1997029772A1 Recombinant canine herpesviruses |
| 08/21/1997 | WO1997029771A1 Immunogenic detoxified mutants of cholera toxin |
| 08/21/1997 | WO1997029770A1 Sarcocystis vaccine |
| 08/21/1997 | WO1997029769A1 Vaccine for b-cell malignancies |
| 08/21/1997 | WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | WO1997007136A3 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 08/21/1997 | CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | CA2245727A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | CA2244800A1 Immunogenic detoxified mutants of cholera toxin |
| 08/21/1997 | CA2243662A1 Recombinant canine herpesviruses |
| 08/21/1997 | CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | CA2241802A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0790309A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790308A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790255A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0789774A2 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 08/20/1997 | EP0789768A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
| 08/20/1997 | EP0789767A1 Purified papillomavirus proteins |
| 08/20/1997 | EP0789766A1 Chimeric papillomavirus-like particles |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789763A1 Icam-4 materials and methods |
| 08/20/1997 | EP0789757A1 Transgenic organisms and their uses |
| 08/20/1997 | EP0789754A1 H. pylori fermentation process |
| 08/20/1997 | EP0789716A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789710A1 Peptides for anti-allergy treatment |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789591A1 Methods for identifying individuals suffering from a cellular abnormality |
| 08/20/1997 | EP0789590A2 Chitosan induced immunopotentiation |
| 08/20/1997 | EP0789587A1 Combined meningitis vaccine |
| 08/20/1997 | EP0789586A1 Compounds for the prevention and treatment of helminth infections |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789563A1 Hepatitis virus vaccines |
| 08/20/1997 | EP0701571B1 Antibody fragments in therapy |
| 08/20/1997 | EP0635001B1 Substituted thioureas as bifunctional chelators |
| 08/20/1997 | EP0593446B1 Monoclonal antibody which distinguishes helper inducer and supressor inducer cd4+ lymphocytes |
| 08/20/1997 | EP0531495B1 Therapeutic and cosmetic compositions for treatment of skin |
| 08/20/1997 | CN1157572A Liquid immunoglobulin formulations |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157560A Implanted device containing tumor cells for treatment of cancer |
| 08/19/1997 | US5658936 Administering dose of renin-angiotensin system inhibitor which modifies acutely systemic blood pressure by less than ten percent |
| 08/19/1997 | US5658803 For diagnosis, prophylaxis, treatment of bacterial infections |
| 08/19/1997 | US5658786 DNA encoding rat taurine transporter and uses thereof |
| 08/19/1997 | US5658785 Adeno-associated virus materials and methods |
| 08/19/1997 | US5658783 Mammalian methadone-specific opioid receptor gene and uses |
| 08/19/1997 | US5658762 DNA molecules, expression vectors and host cells expressing antigenized antibodies |
| 08/19/1997 | US5658757 Cloned leptospira outer membrane protein |
| 08/19/1997 | US5658742 Monoclonal antibody |
| 08/19/1997 | US5658572 Infectious bursal disease virus recombinant poxvirus vaccine |
| 08/19/1997 | US5658569 Anti-HIV-1 neutralizing antibodies |